Brinker Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Brinker Capital’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$243K	Buy	+5,025	New	+$183K	0.01%	866

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SIG

Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return

Brinker Capital's ADPT Position: Q2 2020 in Review

Brinker Capital opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2020: 5,025 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #866 among its holdings.

196 funds tracked by Wall St. Rank hold ADPT as of Q2 2020.

Brinker Capital held 5,025 shares of Adaptive Biotechnologies worth $243K as of Q2 2020.
Adaptive Biotechnologies was a new Brinker Capital position in Q2 2020.
Adaptive Biotechnologies made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #866 holding.
196 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.